Special Issues

Special Issues

We bring you special features throughout the year to enhance the depth of our hematology and oncology coverage

Focus on Myeloid Malignancies (Volume 7, Issue 6.1)

This supplement explores JAK inhibitors for myelofibrosis, cellular therapies for myeloid malignancies, and more.

March 2021 Special Edition

This supplement discusses new immunotherapies for myeloma, the role of transplant in treating patients with peripheral T-cell lymphomas, and more.

Focus on Classical Hematology (Volume 6, Issue 12.1)

This supplement takes a look at new guidelines for the treatment of TTP, the latest FDA approvals for the treatment of red blood cell and iron disorders, and more.

Focus on Myeloid Malignancies (Volume 6, Issue 6.1)

This supplement discusses the value of mutation testing for myeloid malignancies, reevaluates maintenance therapy in AML, and more.

Focus on Lymphoid & Plasma Cell Malignancies (Volume 6, Issue 4.1)

This supplement takes a look at the future of chemoimmunotherapy for chronic lymphocytic leukemia, the latest FDA approvals for the treatment of lymphoid and plasma cell malignancies, and more.

Focus on Classical Hematology (Volume 5, Issue 12.1)

This supplement explores new treatment options for hemophilia, gene therapy in nonmalignant hematologic disorders, and more.

Focus on Myeloid Malignancies (Volume 5, Issue 6.1)

This supplement features FDA updates for the treatment of myeloid malignancies, new questions in acute myeloid leukemia, and more.

Focus on Lymphoid Malignancies (Volume 5, Issue 4.1)

This supplement features a look at the future of Hodgkin lymphoma treatment, the latest approvals for lymphoid malignancies, and more.

Focus on Classical Hematology (Volume 4, Issue 12.1)

In this special edition, we take a look at the latest updates in classical hematology, from a advances in gene therapy for hemophilia to a debate about intravenous iron in pregnant women with iron-deficiency anemia, and more.

Focus on Myeloid Malignancies (Volume 4, Issue 6.1)

This supplement features FDA updates, clinical trials, and the latest research in myeloid malignancies.
Advertisement

Current Issue

July 2021 Bonus Mid-Year Edition, Volume 7 Issue 9

This issue features conversations with ASH Clinical Research Training Institute graduates, highlights from the virtual ASCO and EHA annual meetings, and more.

Block title